Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calender
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Tri-Conference
    • Next Generation Dx
    • Dx Innovation Summit
  • About
    • Editorial Profile
    • Editorial Calender
    • Contact
  • Molecular Med Tri-Conference
 
  • Combination Tests Emerge to Tackle Potential “Twindemic”

    Diagnostics World News | As the coronavirus pandemic overlaps with flu season, some experts say early detection will be especially crucial for battling this double threat. And in recent months, new diagnostic tests have emerged to help distinguish one from the other.

    Nov 2, 2020
  • Cell-Free Antibody Test, Ultrasounds Show Cardiac Impact, Acuity Score Predicts Outcomes: COVID-19 Updates

    Diagnostics World News I Organs-on-Chips technology to evaluate potential vaccines, COVID-19 associated strokes, recovered patients may be asymptomatic carriers, metabolites identified as biomarkers, frontal lobe involvement in abnormal EEGs, and antibodies detectable for several months. Plus: AI-based algorithm predicts acute kidney injury, PerkinElmer screens for COVID-19 and flu in single test, faster more efficient antibody test by U-M scientists, and NYC outbreak linked to European strains of the virus.

    Oct 30, 2020
  • Follow the Money: New Diagnostics for Blood Infection, Dementia, Bone Disease

    Diagnostics World News | Australian company nets cash for finger-prick blood infection diagnostic, AI-powered, “semi-autonomous” bone image diagnostics platform, NIH grants for non-Alzheimer’s dementias, and more.

    Oct 28, 2020
  • ‘Danger Molecule’ Associated With Inflammation, Obesity And Subclinical Cardiovascular Risk—And May Correlate With COVID-19

    Diagnostics World News | It has been known for several years now that a “danger molecule” shows up in the blood when cells in the body are under stress or tissues are injured, inducing a potent inflammatory response—at least in rats. High Mobility Group Box-1 (HMGB1) is in fact one of the best characterized damage-associated molecular patterns.

    Oct 26, 2020
  • «
  • 111
  • 112
  • 113 (current)
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy